Ribosomopathies: human disorders of ribosome dysfunction - PubMed (original) (raw)
Review
Ribosomopathies: human disorders of ribosome dysfunction
Anupama Narla et al. Blood. 2010.
Abstract
Ribosomopathies compose a collection of disorders in which genetic abnormalities cause impaired ribosome biogenesis and function, resulting in specific clinical phenotypes. Congenital mutations in RPS19 and other genes encoding ribosomal proteins cause Diamond-Blackfan anemia, a disorder characterized by hypoplastic, macrocytic anemia. Mutations in other genes required for normal ribosome biogenesis have been implicated in other rare congenital syndromes, Schwachman-Diamond syndrome, dyskeratosis congenita, cartilage hair hypoplasia, and Treacher Collins syndrome. In addition, the 5q- syndrome, a subtype of myelodysplastic syndrome, is caused by a somatically acquired deletion of chromosome 5q, which leads to haploinsufficiency of the ribosomal protein RPS14 and an erythroid phenotype highly similar to Diamond-Blackfan anemia. Acquired abnormalities in ribosome function have been implicated more broadly in human malignancies. The p53 pathway provides a surveillance mechanism for protein translation as well as genome integrity and is activated by defects in ribosome biogenesis; this pathway appears to be a critical mediator of many of the clinical features of ribosomopathies. Elucidation of the mechanisms whereby selective abnormalities in ribosome biogenesis cause specific clinical syndromes will hopefully lead to novel therapeutic strategies for these diseases.
Figures
Figure 1
Simplified schematic of eukaryotic ribosome biogenesis. Adapted from Liu and Ellis with permission.
Figure 2
Selected physical abnormalities seen in ribosomopathies. (A) Left panel: Patient with DBA, illustrating the characteristic craniofacial abnormalities (courtesy of J. Lipton). Note the absent lower eyelashes, deformed external ears, and micrognathia. Second panel: An example of the triphalangeal thumb seen in DBA patients (courtesy of E. Atsidaftos and E. Muir). First panel: Reprinted from Lipton and Ellis with permission. (B) These panels illustrate the diagnostic triad of DKC, including dystrophic fingernails, lacy/reticular pigmentation on neck and trunk, and oral leukoplakia (courtesy of B. Alter). Reprinted from Savage and Alter with permission. (C) The craniofacial abnormalities of a patient with TCS are illustrated (courtesy of M. R. Passos Bueno). Note the down slanting palpebral fissures, malar and maxillary hypoplasia, and malformation of the ears. Reprinted from Passos-Bueno et al with permission.
Figure 3
Potential mechanisms for the cellular consequences of ribosomal haploinsufficiency. (A) Top panel: Normal cell in unstressed conditions, with unperturbed ribosome biogenesis and steady levels of p53. Bottom panel: Ribosomal haploinsufficiency leads to up-regulation of rpL11, which binds to MDM2 causing p53 activation, which results in apoptosis and cell-cycle arrest. (B) Top panel: Normal hemoglobin synthesis, with the coordinated production of heme and globin. Bottom panel: Relative excess of free heme leads to oxidative stress and hemolysis through a variety of mechanisms.
Similar articles
- How Altered Ribosome Production Can Cause or Contribute to Human Disease: The Spectrum of Ribosomopathies.
Venturi G, Montanaro L. Venturi G, et al. Cells. 2020 Oct 15;9(10):2300. doi: 10.3390/cells9102300. Cells. 2020. PMID: 33076379 Free PMC article. Review. - Non-Diamond Blackfan anemia disorders of ribosome function: Shwachman Diamond syndrome and 5q- syndrome.
Burwick N, Shimamura A, Liu JM. Burwick N, et al. Semin Hematol. 2011 Apr;48(2):136-43. doi: 10.1053/j.seminhematol.2011.01.002. Semin Hematol. 2011. PMID: 21435510 Free PMC article. Review. - Activation of the mTOR pathway by the amino acid (L)-leucine in the 5q- syndrome and other ribosomopathies.
Boultwood J, Yip BH, Vuppusetty C, Pellagatti A, Wainscoat JS. Boultwood J, et al. Adv Biol Regul. 2013 Jan;53(1):8-17. doi: 10.1016/j.jbior.2012.09.002. Epub 2012 Sep 13. Adv Biol Regul. 2013. PMID: 23031788 Review. - Acquired ribosomopathies in leukemia and solid tumors.
Vlachos A. Vlachos A. Hematology Am Soc Hematol Educ Program. 2017 Dec 8;2017(1):716-719. doi: 10.1182/asheducation-2017.1.716. Hematology Am Soc Hematol Educ Program. 2017. PMID: 29222326 Free PMC article. Review. - Ribosome defects in disorders of erythropoiesis.
Narla A, Hurst SN, Ebert BL. Narla A, et al. Int J Hematol. 2011 Feb;93(2):144-149. doi: 10.1007/s12185-011-0776-0. Epub 2011 Feb 1. Int J Hematol. 2011. PMID: 21279816 Free PMC article. Review.
Cited by
- BLM helicase facilitates RNA polymerase I-mediated ribosomal RNA transcription.
Grierson PM, Lillard K, Behbehani GK, Combs KA, Bhattacharyya S, Acharya S, Groden J. Grierson PM, et al. Hum Mol Genet. 2012 Mar 1;21(5):1172-83. doi: 10.1093/hmg/ddr545. Epub 2011 Nov 21. Hum Mol Genet. 2012. PMID: 22106380 Free PMC article. - Pediatric MDS and bone marrow failure-associated germline mutations in SAMD9 and SAMD9L impair multiple pathways in primary hematopoietic cells.
Thomas ME 3rd, Abdelhamed S, Hiltenbrand R, Schwartz JR, Sakurada SM, Walsh M, Song G, Ma J, Pruett-Miller SM, Klco JM. Thomas ME 3rd, et al. Leukemia. 2021 Nov;35(11):3232-3244. doi: 10.1038/s41375-021-01212-6. Epub 2021 Mar 17. Leukemia. 2021. PMID: 33731850 Free PMC article. - The human 18S rRNA base methyltransferases DIMT1L and WBSCR22-TRMT112 but not rRNA modification are required for ribosome biogenesis.
Zorbas C, Nicolas E, Wacheul L, Huvelle E, Heurgué-Hamard V, Lafontaine DL. Zorbas C, et al. Mol Biol Cell. 2015 Jun 1;26(11):2080-95. doi: 10.1091/mbc.E15-02-0073. Epub 2015 Apr 7. Mol Biol Cell. 2015. PMID: 25851604 Free PMC article. - An extraribosomal function of ribosomal protein L13a in macrophages resolves inflammation.
Poddar D, Basu A, Baldwin WM 3rd, Kondratov RV, Barik S, Mazumder B. Poddar D, et al. J Immunol. 2013 Apr 1;190(7):3600-12. doi: 10.4049/jimmunol.1201933. Epub 2013 Mar 4. J Immunol. 2013. PMID: 23460747 Free PMC article. - Dried blood spot metabolomics reveals a metabolic fingerprint with diagnostic potential for Diamond Blackfan Anaemia.
van Dooijeweert B, Broeks MH, van Beers EJ, Verhoeven-Duif NM, van Solinge WW, Nieuwenhuis EES, Jans JJ, van Wijk R, Bartels M. van Dooijeweert B, et al. Br J Haematol. 2021 Jun;193(6):1185-1193. doi: 10.1111/bjh.17524. Epub 2021 May 17. Br J Haematol. 2021. PMID: 33997957 Free PMC article. Clinical Trial.
References
- Draptchinskaia N, Gustavsson P, Andersson B, et al. The gene encoding ribosomal protein S19 is mutated in Diamond-Blackfan anaemia. Nat Genet. 1999;21(2):169–175. - PubMed
- Liu JM, Ellis SR. Ribosomes and marrow failure: coincidental association or molecular paradigm? Blood. 2006;107(12):4583–4588. - PubMed
- Doudna JA, Rath VL. Structure and function of the eukaryotic ribosome: the next frontier. Cell. 2002;109(2):153–156. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous